Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
11/2007
11/20/2007US7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/20/2007US7297792 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
11/20/2007US7297708 Central nervous system disorders; psychological disorders
11/20/2007US7297698 e.g. (2R,5S)-4-(3-chloro-4-cyanophenyl)-N-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide; antiandrogenic agent
11/20/2007CA2298821C Supernucleophilic 4-substituted-pyridine catalysts, and processes useful for preparing same
11/15/2007WO2007130898A1 TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1
11/15/2007WO2007129810A1 Synthesis of vinylphenylpyridine and living anionic polymerization
11/15/2007WO2007129664A1 Chiral tetradentate ligand for asymmetric catalytic action and use thereof
11/15/2007WO2007129188A1 Cyclopropanecarboxamide compound
11/15/2007WO2007129040A1 p38 MAP KINASE INHIBITORS
11/15/2007WO2007129036A1 Inhibitors of p38 map kinase
11/15/2007WO2007128752A1 Pyridyl compounds
11/15/2007WO2007128137A1 Poly(arylene ether)s with grafting capability from a bisphenol or bisthiophenol monomer
11/15/2007WO2007095050A3 N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase
11/15/2007WO2007087443A3 Vinyl-phenyl derivatives for inflammation and immune-related uses
11/15/2007WO2007067416A3 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007US20070265450 Novel processes for the preparation of (r)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
11/15/2007US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007US20070265323 Compounds for the treatment of metabolic disorders
11/15/2007US20070265322 Compounds for the treatment of metabolic disorders
11/15/2007US20070265315 An urea compounds containing a pyridine, quinoline, or isoquinoline functionality; p38 mediated diseases such as inflammation and VEGF mediated diseases such as angogenesis disorders
11/15/2007US20070265314 Novel polymorph forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
11/15/2007US20070265290 Male contraceptices; hormone sensitivity diseases; antidepressants; sexual disorders ; osteoporosis; alopecia; prostate cancer
11/15/2007US20070265279 Use of mGluR5 antagonists for the treatment of pruritic conditions
11/15/2007US20070265268 inhibiting heat shock protein 90 (Hsp90) family protein comprising administering benzoic acid derivatives or prodrugs, for the treatment of breast cancer or leukemia
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070265241 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/15/2007CA2650970A1 P38 map kinase inhibitors
11/15/2007CA2649677A1 Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
11/14/2007EP1854786A1 Ionic liquids and their use in extraction processes
11/14/2007EP1854164A1 Polymer ionic electrolytes
11/14/2007EP1853556A1 Derivatives of aminobutanoic acid inhibiting cpt
11/14/2007EP1853538A2 Modulator
11/14/2007EP1853261A1 Selective inhibitors of human corticosteroid synthases
11/14/2007EP1689231A4 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
11/14/2007EP1565442B1 Pyridine derivatives as cb2 receptor modulators
11/14/2007EP1509537B9 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1399423B1 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds
11/14/2007CN101072761A 2-alkyl-cycloalk(en)yl-carboxamides
11/14/2007CN101072756A Method for producing thiocarbamate derivative
11/14/2007CN101072755A Pyridyl inhibitors of hedgehog signalling
11/14/2007CN101072743A Pyrene compound and, utilizing the same, light emitting transistor device and electroluminescence device
11/14/2007CN101071248A Two-order nonlinear laser material 4-nitro-N-oxy-2-pyridine carboxylic acid second-generation crystal, and its growth method and use
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/14/2007CN100348595C Simulated moving bed chromatography separating method of omeprazole antimer
11/14/2007CN100348582C One-step reaction method for preparing 4-nitropyridine-nitrogen oxide and halogenated-4-nitropyridine-nitrogen oxide
11/14/2007CN100348581C Alkoxyniacin preparation method
11/14/2007CN100348580C Taxol enhancer compounds
11/14/2007CN100348319C Catalyst for gas-solid phase synthesis of 2-chloro-5-trichloro methyl pyridine and its prepn
11/13/2007US7294718 Synthesis of a 4-methylthiazole-4(S)-carboxylic acid compound
11/13/2007US7294647 Kappa agonist compounds and pharmaceutical formulations thereof
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007US7294456 Mass labels
11/13/2007US7294415 Organometallic complex and organic electroluminescent device employing the same
11/13/2007US7294369 Polymerisable cinnamates with lateral substitution
11/13/2007CA2345006C New benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmaceutical compositions
11/13/2007CA2248304C Surface modified carbonate materials
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/13/2007CA2157856C Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/08/2007WO2007126957A2 New compounds
11/08/2007WO2007126771A2 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
11/08/2007WO2007126733A2 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
11/08/2007WO2007126060A1 Salt of 1,2-dihydropyridine compound
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125238A1 Specific monocationic monochromophoric compounds of hydrazone type comprising a 2-, 4-pyridinium or 2-, 4-quinolinium unit, synthesis thereof, dye compositions containing them, and method for dyeing keratin fibres
11/08/2007WO2007124546A1 Integrase inhibitors 3
11/08/2007WO2007124545A1 Integrase inhibitors - 2
11/08/2007WO2007104783A3 1,4 -di substituted 3-cyano-pyridone derivatives and their use as positive mglur2-recept0r modulators
11/08/2007WO2007082098A3 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides
11/08/2007WO2007075534A3 Polymer conjugates of glp-1
11/08/2007WO2007070568A3 Demethylpenclomedine analogs and their use as anticancer agents
11/08/2007WO2006106423A8 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
11/08/2007US20070260068 Method for the Preparation of Crystal Forms of Torsemide in a Pure State
11/08/2007US20070260065 Process for preparing amlodipine
11/08/2007US20070259961 Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal or cancer
11/08/2007US20070259919 2-Substituted Pyridines, Processes for their Preparation and Their Use for Controlling Harmful Fungi
11/08/2007US20070259890 Compounds and Compositions as Ppar Modulators
11/08/2007US20070259863 Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives
11/08/2007US20070259849 Azine-Carboxamides as Anti-Cancer Agents
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007CA2650035A1 Poly (ethylene glycol) containing chemically disparate endgroups
11/08/2007CA2647933A1 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
11/08/2007CA2647338A1 Integrase inhibitors-3
11/08/2007CA2644530A1 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
11/07/2007EP1851210A2 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
11/07/2007EP1851202A1 Pyridyl acetic acid compounds
11/07/2007EP1851193A1 Hiv protease inhibitors
11/07/2007EP1648869B1 Process for the production of pyridine and picolines
11/07/2007EP1623977B1 Intermediate compound which is used for the preparation of pioglitazone
11/07/2007EP1613597B1 6-substituted nicotinamide derivatives as opioid receptor antagonists
11/07/2007EP1513526B1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
11/07/2007EP1400521B1 Piperazine compounds
11/07/2007EP1087941B9 Thiolesters and uses thereof
11/07/2007CN101068916A Use of atazanavir for improving the pharmacokinetics of drugs metabolized by UGT1A1
11/07/2007CN101068805A Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
11/07/2007CN101068804A Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use
11/07/2007CN101068803A Biaryloxymethylarene carboxylic acid compounds
1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 633